End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.5 EUR | +4.17% | 0.00% | -8.09% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 18.75 | 20.25 | 26.7 | 21.75 | 26.25 | 27.69 |
Enterprise Value (EV) 1 | 39.08 | 51.22 | 56.12 | 44.3 | 45.97 | 57.8 |
P/E ratio | 8.56 x | 7.74 x | 7.72 x | 5.85 x | 8.74 x | 7.65 x |
Yield | 0.42% | 0.74% | 1.12% | 2.07% | 1.71% | 1.97% |
Capitalization / Revenue | 0.34 x | 0.35 x | 0.42 x | 0.36 x | 0.43 x | 0.42 x |
EV / Revenue | 0.71 x | 0.87 x | 0.89 x | 0.74 x | 0.76 x | 0.88 x |
EV / EBITDA | 7.58 x | 7.38 x | 7.14 x | 5.65 x | 6.97 x | 7.22 x |
EV / FCF | -1.29 x | -4.73 x | -361 x | 8.38 x | 37.9 x | 28.8 x |
FCF Yield | -77.5% | -21.2% | -0.28% | 11.9% | 2.64% | 3.47% |
Price to Book | 0.98 x | 0.93 x | 1.06 x | 0.76 x | 0.85 x | 0.81 x |
Nbr of stocks (in thousands) | 1,950 | 1,950 | 1,950 | 1,950 | 1,950 | 1,950 |
Reference price 2 | 9.615 | 10.38 | 13.69 | 11.15 | 13.46 | 14.20 |
Announcement Date | 7/19/18 | 7/12/19 | 6/19/20 | 6/10/21 | 6/8/22 | 6/8/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 55.39 | 58.61 | 62.93 | 59.95 | 60.73 | 65.92 |
EBITDA 1 | 5.156 | 6.937 | 7.857 | 7.847 | 6.593 | 8.01 |
EBIT 1 | 2.952 | 4.223 | 4.316 | 4.296 | 2.948 | 4.429 |
Operating Margin | 5.33% | 7.2% | 6.86% | 7.17% | 4.85% | 6.72% |
Earnings before Tax (EBT) 1 | 2.672 | 3.679 | 3.976 | 4.512 | 3.374 | 4.168 |
Net income 1 | 2.189 | 2.617 | 3.457 | 3.718 | 3.003 | 3.622 |
Net margin | 3.95% | 4.46% | 5.49% | 6.2% | 4.94% | 5.49% |
EPS 2 | 1.123 | 1.342 | 1.773 | 1.907 | 1.540 | 1.857 |
Free Cash Flow 1 | -30.27 | -10.83 | -0.1557 | 5.285 | 1.214 | 2.006 |
FCF margin | -54.65% | -18.48% | -0.25% | 8.82% | 2% | 3.04% |
FCF Conversion (EBITDA) | - | - | - | 67.35% | 18.41% | 25.05% |
FCF Conversion (Net income) | - | - | - | 142.15% | 40.42% | 55.39% |
Dividend per Share 2 | 0.0400 | 0.0769 | 0.1538 | 0.2308 | 0.2308 | 0.2800 |
Announcement Date | 7/19/18 | 7/12/19 | 6/19/20 | 6/10/21 | 6/8/22 | 6/8/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 20.3 | 31 | 29.4 | 22.6 | 19.7 | 30.1 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 3.943 x | 4.465 x | 3.745 x | 2.874 x | 2.991 x | 3.758 x |
Free Cash Flow 1 | -30.3 | -10.8 | -0.16 | 5.29 | 1.21 | 2.01 |
ROE (net income / shareholders' equity) | 12.1% | 12.8% | 14.8% | 13.9% | 10.1% | 11.1% |
ROA (Net income/ Total Assets) | 3.55% | 3.53% | 3.58% | 3.53% | 2.4% | 3.59% |
Assets 1 | 61.63 | 74.18 | 96.54 | 105.4 | 125.2 | 100.9 |
Book Value Per Share 2 | 9.860 | 11.20 | 12.90 | 14.60 | 15.90 | 17.50 |
Cash Flow per Share 2 | 12.40 | 5.750 | 5.320 | 7.550 | 7.710 | 1.180 |
Capex 1 | 32.5 | 13.5 | 5.16 | 1.34 | 2.95 | 1.77 |
Capex / Sales | 58.74% | 23.03% | 8.2% | 2.23% | 4.85% | 2.68% |
Announcement Date | 7/19/18 | 7/12/19 | 6/19/20 | 6/10/21 | 6/8/22 | 6/8/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-8.09% | 26.02M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.59B | |
-12.71% | 16.73B | |
-2.32% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-0.11% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- JTH Stock
- Financials Gesundheitswelt Chiemgau AG